logo

Allena Pharmaceuticals, Inc. (ALNA)



Trade ALNA now with
  Date
  Headline
8/12/2019 7:49:13 AM Wedbush Is Raising Allena Pharmaceuticals, Inc. (ALNA) FY20 Estimate To -1.19 From -1.22
8/12/2019 7:48:55 AM Wedbush Is Increasing Allena Pharmaceuticals, Inc. (ALNA) Q4 20 Estimate To -0.26 From -0.27
8/12/2019 7:48:07 AM Wedbush Is Increasing Allena Pharmaceuticals, Inc. (ALNA) Q3 20 Estimate To -0.26 From -0.27
8/12/2019 7:47:45 AM Wedbush Is Increasing Allena Pharmaceuticals, Inc. (ALNA) Q2 20 Estimate To -0.30 From -0.31
8/12/2019 7:47:30 AM Wedbush Is Raising Allena Pharmaceuticals, Inc. (ALNA) Q1 20 Estimate To -0.36 From -0.37
8/12/2019 7:47:12 AM Wedbush Is Increasing Allena Pharmaceuticals, Inc. (ALNA) FY19 Estimate To -1.93 From -1.96
8/12/2019 7:46:58 AM Wedbush Is Raising Allena Pharmaceuticals, Inc. (ALNA) Q4 19 Estimate To -0.42 From -0.44
8/12/2019 7:46:43 AM Wedbush Is Raising Allena Pharmaceuticals, Inc. (ALNA) Q3 19 Estimate To -0.44 From -0.46
8/12/2019 7:46:01 AM Wedbush Reiterates Allena Pharmaceuticals, Inc. (ALNA) At Outperform With $36 Price Target
6/27/2019 9:01:45 PM Allena Pharma Announces $10.0 Mln Registered Direct Offering Of Common Stock
4/17/2019 8:09:06 AM Allena Pharmaceuticals Appoints Allene Diaz To Its Board
1/4/2019 8:05:49 AM Allena Appoints Louis Brenner CEO; Alexey Margolin To Transition To Chairman
1/2/2019 8:07:30 AM Allena Says Achieves Alignment With FDA On Phase 3 Program And Accelerated Approval Pathway For Reloxaliase
11/7/2018 8:08:52 AM Allena Pharmaceuticals Q3 Net Loss $9.5 Mln Or $0.46/Shr Vs Net Loss $4.7 Mln Or $3.49/Shr Last Year
10/22/2018 8:12:42 AM Allena Announces Preclinical Proof-of-concept Data For ALLN-346
8/7/2018 8:10:00 AM Allena Pharma Q2 Net Loss $8.6 Mln Or $0.42/Shr Vs Loss $4.6 Mln Or $3.46/Shr Last Year
7/24/2018 9:31:04 AM Wedbush Reiterates Allena Pharmaceuticals, Inc. (ALNA) At Outperform With $38 Price Target